Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Thoracic cancer patients and Covid-19: experience from a portuguese tertiary care unit

Raquel Viana, Daniel Coutinho, Eloísa Silva, Sérgio Campainha, Margarida Dias, Telma Costa, Ana Barroso
European Respiratory Journal 2021 58: PA3850; DOI: 10.1183/13993003.congress-2021.PA3850
Raquel Viana
1Centro Hospitalar de Leiria, Leiria, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: raquelviana2@gmail.com
Daniel Coutinho
2Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eloísa Silva
2Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sérgio Campainha
2Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margarida Dias
2Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Telma Costa
2Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Barroso
2Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

-Cancer patients have higher risk of Covid-19 infection and may develop severe disease with increased mortality. Thoracic CancERs International CoVid-19 COLlaboraTion Registry (Teravolt) is a global consortium that assesses outcomes in this group of patients.

-Describe TERAVOLT results in a portuguese tertiary care hospital.

-Descriptive study. Patients diagnosed with COVID-19 at Centro Hospitalar Vila Nova de Gaia Thoracic Tumors Unit between march 2020 and january 2021 were included. Demographic, clinical, pathological and radiological data were collected.

-31 patients: 71% males, mean age 65,2. 74,2% had non small cell lung carcinoma. Most patients had ECOG PS 1. Disease stage was diverse (IV-63%; III-18,5%; II-3,7%; I-14,8%). 77,4% presented comorbidities. 59,1% were not receiving treatment at time of COVID-19 diagnosis. Fatigue and dyspnea were the most common symptoms; 29% were asymptomatic. 41,9% were hospitalized, none was admitted to the intensive care unit. Pneumonia was the most frequent complication. Death rate was 16,1%.

-Compared to TERAVOLT published results, there is a lower death rate in our population (16,1% vs. 32%). All deaths occurred in stage IV patients with ECOG PS 2-3, who were diagnosed with COVID-19 during hospitalization. The percentage of asymptomatic patients may be explained by mandatory SARS-CoV-2 PCR screening tests performed before treatments and invasive procedures. Telephonic visits, less frequent immunotherapy dosing schedules and tyrosine kinase inhibitors given for a 2-month period were implemented measures to prevent unnecessary hospital visits. Protocols regarding infection control measures and treatment options in this group of patients should be created.

  • Covid-19
  • Lung cancer

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3850.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thoracic cancer patients and Covid-19: experience from a portuguese tertiary care unit
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Thoracic cancer patients and Covid-19: experience from a portuguese tertiary care unit
Raquel Viana, Daniel Coutinho, Eloísa Silva, Sérgio Campainha, Margarida Dias, Telma Costa, Ana Barroso
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3850; DOI: 10.1183/13993003.congress-2021.PA3850

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Thoracic cancer patients and Covid-19: experience from a portuguese tertiary care unit
Raquel Viana, Daniel Coutinho, Eloísa Silva, Sérgio Campainha, Margarida Dias, Telma Costa, Ana Barroso
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3850; DOI: 10.1183/13993003.congress-2021.PA3850
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Guide sheath method for rEBUS-guided biopsy of peripheral pulmonary lesions
  • Glucosamine use and the risk of lung cancer
  • Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: Three case studies
Show more Lung cancer

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society